secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001213900-24-008016
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt acquires Brain Scientific EEG assets; issues $6M Series B-1 preferred
----------------------------------------------------------------------------

- Acquisition includes 16 patents and flagship NeuroCap™ and NeuroEEG™ products for neurology.
- Aditxt issued 6,000 shares of Series B-1 Convertible Preferred Stock (stated value $6M) to Brain Scientific creditors.
- Aditxt exchanged a $2.625M secured promissory note for 2,625 shares of Series B-2 Convertible Preferred Stock.
- Global EEG devices market valued at $1.06B in 2022, expected to grow at 10.2% CAGR through 2030.
- Acquired assets assigned to Pearsanta, Aditxt's majority-owned subsidiary, entering neurological diagnostics market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/0001213900-24-008016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/ea192454-8k_aditxtinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-008016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer